Risperidone in the treatment of psychotic depression

Chanoch Miodownik; Vladimir Lerner

doi:10.1097/00002826-200011000-00007

Risperidone in the treatment of psychotic depression

Chanoch Miodownik, Vladimir Lerner

Research output: Contribution to journal › Article › peer-review

16 Scopus citations

Abstract

Risperidone has been primarily marketed for the treatment of schizophrenia. There are reports about its potential role for the treatment of affective illness. We report here another case of a patient with psychotic depression who was treated successfully with risperidone as monotherapy. This case report suggests that risperidone can be an efficient treatment mode for psychotic depression; however, it needs more data based on controlled study.

Original language	English
Pages (from-to)	335-337
Number of pages	3
Journal	Clinical Neuropharmacology
Volume	23
Issue number	6
DOIs	https://doi.org/10.1097/00002826-200011000-00007
State	Published - 1 Dec 2000

Keywords

5HT receptors
Monotherapy
Psychotic depression
Risperidone
α2-adrenergic affinities

ASJC Scopus subject areas

Pharmacology
Clinical Neurology
Pharmacology (medical)

Access to Document

10.1097/00002826-200011000-00007

Cite this

@article{662db0017ae248e2bd526e078eb6237f,

title = "Risperidone in the treatment of psychotic depression",

abstract = "Risperidone has been primarily marketed for the treatment of schizophrenia. There are reports about its potential role for the treatment of affective illness. We report here another case of a patient with psychotic depression who was treated successfully with risperidone as monotherapy. This case report suggests that risperidone can be an efficient treatment mode for psychotic depression; however, it needs more data based on controlled study.",

keywords = "5HT receptors, Monotherapy, Psychotic depression, Risperidone, α2-adrenergic affinities",

author = "Chanoch Miodownik and Vladimir Lerner",

note = "Funding Information: This study was supported in part by a Research Grant for Nervous and Mental Disorders from the Ministry and Welfare, Japan and also by a grant from the Pharmaco Psychiatry Fundation, Osaka, Japan.",

year = "2000",

month = dec,

day = "1",

doi = "10.1097/00002826-200011000-00007",

language = "English",

volume = "23",

pages = "335--337",

journal = "Clinical Neuropharmacology",

issn = "0362-5664",

publisher = "Lippincott Williams and Wilkins",

number = "6",

}

TY - JOUR

T1 - Risperidone in the treatment of psychotic depression

AU - Miodownik, Chanoch

AU - Lerner, Vladimir

N1 - Funding Information: This study was supported in part by a Research Grant for Nervous and Mental Disorders from the Ministry and Welfare, Japan and also by a grant from the Pharmaco Psychiatry Fundation, Osaka, Japan.

PY - 2000/12/1

Y1 - 2000/12/1

N2 - Risperidone has been primarily marketed for the treatment of schizophrenia. There are reports about its potential role for the treatment of affective illness. We report here another case of a patient with psychotic depression who was treated successfully with risperidone as monotherapy. This case report suggests that risperidone can be an efficient treatment mode for psychotic depression; however, it needs more data based on controlled study.

AB - Risperidone has been primarily marketed for the treatment of schizophrenia. There are reports about its potential role for the treatment of affective illness. We report here another case of a patient with psychotic depression who was treated successfully with risperidone as monotherapy. This case report suggests that risperidone can be an efficient treatment mode for psychotic depression; however, it needs more data based on controlled study.

KW - 5HT receptors

KW - Monotherapy

KW - Psychotic depression

KW - Risperidone

KW - α2-adrenergic affinities

UR - https://www.scopus.com/pages/publications/0034518578

U2 - 10.1097/00002826-200011000-00007

DO - 10.1097/00002826-200011000-00007

M3 - Article

AN - SCOPUS:0034518578

SN - 0362-5664

VL - 23

SP - 335

EP - 337

JO - Clinical Neuropharmacology

JF - Clinical Neuropharmacology

IS - 6

ER -

Risperidone in the treatment of psychotic depression

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this